BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity.
Our Unique Approach
BPGbio is the world’s foremost human biology-focused biopharma company. We take a bold, hypotheses free approach to the drug discovery process.
Our Focus
The Power of NAi – Our AI-Powered Platform
With five drug candidates phase II/III ready and over a hundred drug and diagnostic targets discovered, BPGbio is leading the field in putting the first AI-developed drug onto the market and proving the concept of AI drug discovery.
A Robust & Growing Pipeline
As a biotech company, BPGbio’s mission is to deliver more optimized medicine for a healthier future. Harnessing unbiased data from our own biobank and leveraging purposely built AI, we are developing a range of transformative therapies aimed at addressing unmet medical needs.
Partner with Us
Unlock unparalleled potential with BPGbio! We invite forward-thinking organizations to partner with us. Whether it’s licensing our assets or harnessing the power of NAi for new discovery, we’re committed to creating strong relationships that drive success.
Patents
With over 400 US and international patents, BPGbio’s intellectual property portfolio reinforces our leadership in bioscience, offering partners and investors a foundation of exclusivity and fostering revolutionary advancements in the healthcare landscape.
Clinical Trials
Clinical trials are where innovation meets verification. The progress BPGbio is making in clinical trials represents the strongest testament to the efficacy of our AI-powered drug discovery platform – the NAi Interrogative Biology® platform.
Pancreatic Cancer Glioblastoma (GBM) Epidermolysis Bullosa (EB) Sarcopenia Chemo-Induced Alopecia (CIA)